BioVie Inc at RedChip Investor Webinar Transcript - Thomson StreetEvents

BioVie Inc at RedChip Investor Webinar Transcript

BioVie Inc at RedChip Investor Webinar Transcript - Thomson StreetEvents
BioVie Inc at RedChip Investor Webinar Transcript
Published Oct 08, 2025
12 pages (7736 words) — Published Oct 08, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BIVI.OQ corporate analyst meeting

  
Brief Excerpt:

...Hello. This is Craig Brelsford with RedChip Companies. Thank you for joining today's event with BioVie, which trades on the Nasdaq under the ticker BIVI. With us today, we have Cuong Do, President and CEO of BioVie. (Event Instructions) Before we begin, please allow me to read the Safe Harbor statement. This call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements. Of course, forward-looking statements involve risks and uncertainties. I now turn this webinar over to Cuong. Go ahead. Cuong Do ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Biovie Inc
Ticker
BIVI.OQ
Time
8:15pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Thank you very much, Cuong. (Event Instructions) Cuong, what is the size of the market for your ascites drug? What do you expect the FDA to do by the end of the month?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Lance, well, we have someone who wants to speak to you. Come, Lance, please, unmute your line and Cuong is ready to speak to you. Unidentified Participant Yeah. I was wondering, with the ascites, do you have any information or any follow-up on the patients that were in the Phase 2 trial, the ones that did so well. Do you have -- is there any follow-up on that information?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Thank you very much, Lance. Cuong, what is the status of the once daily bezisterim pill?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Cuong, you may be having bandwidth issues and I'm suggesting that you cut your video and go only, yeah, thank you. (Event Instructions) Cuong, we already have some questions here written in. Why do you only feel 10% of Parkinson's patients would take bezisterim? I would think, given the results so far, every patient would want it.

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Thanks, Cuong. Have you had any discussions with any major pharmaceutical companies for funding?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : How long would a Phase 3 trial last for ascites?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : What is the status of the class action and is it a large drain on resources?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Could you clarify ascites, please? Phase three trial begins mid-2026 and lasts 18 to 24 months.

Question: Craig Brelsford - RedChip Companies Inc - Analyst : (Event Instructions) Immune Bio was another company focusing on TNF-A and its recent clinical results were not as good as hoped. Did that trial provide any useful information about the method of action of bezisterim?

Question: Craig Brelsford - RedChip Companies Inc - Analyst : Thank you very much, Cuong, and thank you, everyone, for all of your questions. For more information about BioVie, reach us at 1800-REDCHIP or e-mail us at bivi@redchip.com. Please visit RedChip's Investor Information page for BioVie. It's biviinfo.com. There, you can view and download the investor presentation and fact sheet and sun up for news alerts on BioVie. Please be sure to watch small stocks, big money, RedChip's program featuring exciting small cap companies every Saturday night at 7:00 PM Eastern on Bloomberg USA. Join RedChip's next webinar with FatPipe on Wednesday, October 15 at 4:15 PM US Eastern. Register for all RedChip webinars at redchip.com/events, where you can also view an archived version of today's webinar. Thank you to our many participants today, and thank you, Cuong. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. OCTOBER 08, 2025 / 8:15PM, BIVI.OQ - BioVie Inc at RedChip Investor Webinar

Table Of Contents

BioVie Inc at RedChip Investor Webinar Transcript – 2025-12-09 – US$ 54.00 – Edited Transcript of BIVI.OQ corporate analyst meeting</ 9-Dec-25 9:15pm GMT

BioVie Inc Annual Shareholders Meeting Transcript – 2025-11-10 – US$ 54.00 – Edited Transcript of BIVI.OQ shareholder or annual meeting 10-Nov-25 7:00pm GMT

BioVie Inc Extraordinary Shareholders Meeting Transcript – 2025-06-23 – US$ 54.00 – Edited Transcript of BIVI.OQ shareholder or annual meeting 23-Jun-25 9:00pm GMT

BioVie Inc Virtual KOL Event Transcript – 2025-05-28 – US$ 54.00 – Edited Transcript of BIVI.OQ corporate analyst meeting</ 28-May-25 4:00pm GMT

BioVie Inc to Host Key Opinion Leader (KOL) Event Transcript – 2025-04-10 – US$ 54.00 – Edited Transcript of BIVI.OQ corporate analyst meeting</ 10-Apr-25 2:00pm GMT

BioVie Inc Annual Shareholders Meeting Transcript – 2024-11-27 – US$ 54.00 – Edited Transcript of BIVI.OQ shareholder or annual meeting 27-Nov-24 6:00pm GMT

BioVie Inc at RedChip Investor Webinar Transcript – 2024-11-07 – US$ 54.00 – Edited Transcript of BIVI.OQ corporate analyst meeting</ 7-Nov-24 9:15pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "BioVie Inc at RedChip Investor Webinar Transcript" Oct 08, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/BioVie-Inc-at-RedChip-Investor-Webinar-T16517311>
  
APA:
Thomson StreetEvents. (2025). BioVie Inc at RedChip Investor Webinar Transcript Oct 08, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/BioVie-Inc-at-RedChip-Investor-Webinar-T16517311>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.